Familial Hemophagocytic Lymphohistiocytosis: Clinical Review Based on the Findings in Seven Children
- 1 March 1991
- journal article
- case report
- Published by Wiley in Acta Paediatrica
- Vol. 80 (3) , 269-277
- https://doi.org/10.1111/j.1651-2227.1991.tb11849.x
Abstract
Clinical, laboratory, and histological findings in FHL of diagnostic importance were intermittent fever, hepatosplenomegaly, peripheral blood cytopenia, hypertriglyceridemia, hypofibrinogenemia, and a lymphohistiocytic accumulation with hemophagocytosis in the mononuclear phagocytic system. Fine-needle aspiration biopsy from the spleen appeared to be a useful method for revealing hemophagocytosis. The treatment of induction and relapses, as well as the maintenance therapy, included administration of teniposide, etoposide, and corticosteroids. The regimen had to be individualized for each child since the clinical course was highly variable. Half of the children given successful induction therapy (3/6) are still alive with over a 3-year survival after diagnosis.Keywords
This publication has 15 references indexed in Scilit:
- Incidence in Sweden and Clinical Features of Familial Hemophagocytic LymphohistiocytosisActa Paediatrica, 1991
- HISTIOCYTOSIS SYNDROMES IN CHILDRENThe Lancet, 1987
- SUCCESSFUL INDUCTION WITH CHEMOTHERAPY INCLUDING TENIPOSIDE IN FAMILIAL ERYTHROPHAGOCYTIC LYMPHOHISTIOCYTOSISThe Lancet, 1986
- Allogeneic bone marrow transplantation for erythrophagocytic lymphohistiocytosisThe Journal of Pediatrics, 1986
- Etoposide (VP-16–213)New England Journal of Medicine, 1985
- Genetic analysis of familial erythrophagocytic lymphohistiocytosisEuropean Journal of Pediatrics, 1984
- Familial hemophagocytic lymphohistiocytosisEuropean Journal of Pediatrics, 1983
- The clinical pharmacology of VM26 and VP16-213Cancer Chemotherapy and Pharmacology, 1982
- X-LINKED RECESSIVE PROGRESSIVE COMBINED VARIABLE IMMUNODEFICIENCY (DUNCAN'S DISEASE)The Lancet, 1975
- Familial Haemophagocytic ReticulosisArchives of Disease in Childhood, 1952